Pharmafile Logo
Pharmafocus logo
Advanced Search
facemask

Men most likely to exhibit the worst COVID-19 symptoms, according to a new study

April 30, 2020
Business Services COVID-19, coronavirus

Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …

News
korean_1

Arizona GOP lawmakers and AAPS say hydroxychloroquine has 90% chance of helping COVID-19 patients, but data is not based on clinical trials

April 29, 2020
Research and Development chloroquine, hydroxychloroquine

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider …

News
shutterstock

Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer

April 29, 2020
Research and Development Cancer, Libtayo, Regeneron, Sanofi, lung cancer

A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung …

News
aussss

Australia calls for investigation into China’s coronavirus response

April 29, 2020
Research and Development Australia, COVID-19, China, coronavirus

Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

April 29, 2020
Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …

News
novartis_outside_1

EU approval for Novartis’ Cosentyx in active non-radiographic axial spondyloarthritis

April 29, 2020
Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma

Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …

News

Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey

April 28, 2020
Manufacturing and Production COVID-19, coronavirus, survey

Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …

News
pharmafocus_may_2020_cover

The May 2020 issue of Pharmafocus is available to read free online now!

April 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!

News
janssen_latest_logo_on_sign_closer

NICE backtracks to approve Janssen’s Stelara in ulcerative colitis

April 28, 2020
Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis

NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …

News
korean

South Korean researchers start testing pancreatitis drug in COVID-19 patients

April 28, 2020
Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …

News
children_with_mask

12 British children hospitalised with rare condition linked to COVID-19

April 28, 2020
Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus

12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …

News

Reinventing the value equation

April 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

Feature

Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up

April 27, 2020
Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …

News
italy_lockdown

Italy to relax COVID-19 lockdown in early May

April 27, 2020
Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …

News
researchers

Researchers studying heartburn drug as potential coronavirus treatment

April 27, 2020
Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …

News
hazmat

‘Excess deaths’ in England among the highest in Europe

April 27, 2020
Sales and Marketing COVID-19, coronavirus, deaths, pandemic

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …

News
images_1

FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine

April 27, 2020
Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …

News
aloe-vera-2417091_960_720

European Medicines Agency’s review of Picato finds its risks outweigh its benefits

April 24, 2020
Business Services, Medical Communications, Sales and Marketing

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …

News
gilead-sciences

Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial

April 24, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

April 24, 2020
Medical Communications COVID-19, coronavirus, top 10

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026